Events
The Dutch company Xenikos B.V., which develops innovative immunotherapies for treating patients with severe immune disease and post-transplant rejection, reports data from an expanded access program using T-Guard to treat steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.
BioIVT announced that it is hosting a drug discovery webinar that will discuss how small interfering RNA molecules can be used to selectively suppress hepatic genes in an in vitro liver model and advance the development of small molecule and nucleic acid therapies.
Alector, Inc., a clinical stage biotechnology company pioneering immuno-neurology, reported safety and biomarker data from the single ascending dose phase of the INVOKE Phase1 study of its product candidate, AL002, in healthy volunteers.
Shares of Alexion Pharmaceuticals have jumped nearly 5% after the company’s board of directors rejected a push for a sale of the company from one of its largest stakeholders, U.K.-based Elliott Advisors, Ltd.
The pharmaceutical company, Biogen presented further analysis from two phase III trials of the potential new Alzheimer’s drug, aducanumab.
Scientists presented more than 25 abstracts demonstrating how Droplet Digital PCR guides treatment decisions at the Association of Molecular Pathology 2019 Annual Meeting and Expo in Baltimore on November 7–9.
The Career Conversation Forum, part of the February 19-20, 2020 Life Science Women’s Conference at the Tampa Convention Center, will present women at all stages of their life science career, or those interested in life sciences, with information on career paths, salary expectations, and day-to-day activities from women who have these experiences.
Apogenix announced that new data on its lead immuno-oncology candidate asunercept will be presented in a poster at the ESMO Immuno-Oncology Congress 2019, held from December 11-14, 2019, at the Palexpo in Geneva, Switzerland.
MC Services AG, a leading international public relations and investor relations firm, announced today that it will be, for the first time, a media partner for Biotech ShowcaseTM.
GeoVax Labs, Inc., a biotechnology company specializing in developing human vaccines, announced that its Chief Scientific Officer, Farshad Guirakhoo, PhD, will be a featured speaker at the World Vaccine & Immunotherapy conference, being held December 2-5, 2019 in San Francisco, California.
PRESS RELEASES